About: JCO Precision Oncology

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: JCO Precision Oncology Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

online medical journal

Attributes	Values
rdf:type	Item
description	online medical journal (en)
language of work or name	wds:Q89051819-19DB294B-C8AE-438B-BE36-837D735D0ACC
language of work or name	English
Scilit journal ID	wds:Q89051819-768642F7-3BAB-4512-88EE-612A3892D314
Crossref journal ID	wds:Q89051819-511D2F94-9062-4C5B-8749-8D30811794BF
Scilit journal ID	1170145
Crossref journal ID	307160
rdfs:label	JCO Precision Oncology (en)
skos:prefLabel	JCO Precision Oncology (en)
name	JCO Precision Oncology (en)
title	wds:Q89051819-80cf8355-4488-e8e6-e68f-8709bef4ff03
title	JCO Precision Oncology (en)
NLM Unique ID	wds:Q89051819-a0582769-4b0f-b4c3-542a-cdc6bad35208
HAL journal ID	wds:Q89051819-927816AB-5A00-4904-8623-70326F382D02
NLM Unique ID	101705370
HAL journal ID	158712
instance of	wds:Q89051819-A87EDBF8-A41F-49C1-9F18-E730E0282751
instance of	medical journal
main subject	wds:Q89051819-75b5e12c-4f29-7282-1f47-a009e198b0b4
main subject	oncology
publisher	wds:Q89051819-F7E3AEF6-0A07-4D47-9A43-D21752DD1467
publisher	American Society of Clinical Oncology
OCLC control number	wds:Q89051819-d06bf02b-4699-6307-ac9f-e23e8100d18e
OCLC control number	http://www.worldcat.org/oclc/953573973
OCLC control number	953573973
skos:altLabel	JCO PO (en) JCO Precis Oncol (en)
OpenAlex ID	wds:Q89051819-EFBD5BF5-D32D-4C17-B386-6DF304A08E37
country of origin	wds:Q89051819-76430EDA-6CB6-4393-AE0B-DAEE1281E565
official website	wds:Q89051819-0213E890-5777-4BD1-AFB9-0FA1D47637E1 wds:Q89051819-831cb1b0-4be6-f0ec-1143-edcb49c4c8f3
OpenAlex ID	V4210227748
country of origin	United States of America
official website	http://po.jco.org https://ascopubs.org/journal/po
ISSN	wds:Q89051819-bdc857c6-4b58-4e35-fd75-eea908fa8a3f
ISSN-L	wds:Q89051819-F5E3E346-A2FA-4125-A41B-5092FA5C5CA7
indexed in bibliographic review	wds:Q89051819-5BCF723F-AB81-4B3C-BEA1-265B5308BA7B
ISSN	urn:ISSN:2473-4284
ISSN-L	http://issn.org/resource/ISSN/2473-4284
ISSN	2473-4284
ISSN-L	2473-4284
indexed in bibliographic review	Science Citation Index Expanded
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q89051819
is published in of	Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data Clinical Utility of CLIA-Grade AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type Sporadic Malignant Glomus Tumor of the Brachial Plexus With Response to Targeted Therapy Directed Against Oncogenic BRAF Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) C Analysis of MDM2 Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors Response to Selective RET Inhibition With LOXO-292 in a Patient With RET Fusion-Positive Lung Cancer With Leptomeningeal Metastases Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease Progression Activity of Brigatinib in Crizotinib and Ceritinib-Resistant ROS1- Rearranged Non-Small-Cell Lung Cancer Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy Duality of purpose: Participant and parent understanding of the purpose of genomic tumor profiling research among children and young adults with solid tumors Whole-Genome and Whole-Exome Sequencing in Pediatric Oncology: An Assessment of Parent and Young Adult Patient Knowledge, Attitudes, and Expectations Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer Targeting ERBB2 (HER2) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional Indications Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in Practice Neuroendocrine Tumors Are Enriched in Cowden Syndrome Severe Capecitabine Toxicity Associated With a Rare DPYD Variant Identified Through Whole-Genome Sequencing Prolonged Complete Response With Combined Dabrafenib and Trametinib After BRAF Inhibitor Failure in BRAF-Mutant Glioblastoma Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year Period Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology Endometrial Cancers in BRCA1 or BRCA2 Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects Pathogenic germline BRCA1/2 mutations and familial predisposition to gastric cancer Subgrouping of Unfavorable Histology Neuroblastomas With Immunohistochemistry Toward Precision Prognosis and Therapy Stratification PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an STRN-NTRK2 Fusion Applying Precision Oncology Principles in Radiation Oncology Predisposition to Lung Adenocarcinoma in a Family Harboring the Germline EGFR V843I Mutation Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software